BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

download BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

of 33

Transcript of BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    1/33

    BLOOD AND BLOOD COMPONENTS

    COLLECTIONTRANSFUSION AND

    PRESERVATION OF BLOOD

    PRESENTED BY

    DR ABAS RASHID BHATMVSC SCHOLAR IST YEAR

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    2/33

    REASONS OF BLOOD COLLECTIONBlood Tests

    Transfusion

    Blood Biochemistry

    Pathogen identification

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    3/33

    METHODSBlood samples are collected by venal

    puncture on live animal, as cleanly aspossible, using sterile equipment, and with

    respect for the welfare of the animal.

    Use new needle and syringe for each animal.

    Dispose needles properly,

    Clean the puncture area with 70% alcohol,Handle animals calmly and using appropriate

    restraint,

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    4/33

    Cont Although most techniques do not

    require large amount of blood it is

    preferable to collect at least2.5mL of blood, but ideally 10mLin large animals, and 4-6mL in

    small animals.

    Identify the sample with a

    permanent method and fill thesampling form at the time ofsampling.

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    5/33

    SITES OF BLOOD COLLECTION Jugular veins (large animals),

    Brachial, brachiocephalic, femoral, tarsal veins,

    Cranial Vena cava in pigs,

    Mammary veins,

    Ear veins in pigs: 20 gauge needle,

    Saphenous veins, retro-orbital veins, intracardial

    punction in rodents, small vertebrates, use a 23

    gauge needle,

    Wings (brachial) in chicken, use 20 to 23 gauge

    needle.

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    6/33

    PRECAUTIONWhole blood is prone to hemolysis.

    Preferentially use a vacutainer instead of asyringe

    If you have to transfer the blood from a syringe

    to a sample container, remove the needle firstand transfer slowly and smoothly

    Do not shake the blood.

    Do not freeze whole blood.

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    7/33

    TRANSFERRING OF BLOOD.BLOOD TRANSFER

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    8/33

    Whole blood samples preservation

    WHOLE BLOOD means with allConstituents

    the blood needs to be stored properly , withan anticoagulant. Different anticoagulants are

    available in commercial tubes such as: EDTA(purple tubes) or Heparin (green tubes).However EDTA is often recommended.For virology antibiotics may be added. 200units of penicillin and 200 mg of streptomycinper ml of blood.

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    9/33

    Whole blood samples should be sent to the

    laboratory in an insulated container with ice

    at 4C.

    .They should not be frozen.

    ->Blood samples for virology must be sent tothe laboratory within 24 to 72 hours

    depending on virus survivability.

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    10/33

    PLASMA COLLECTION

    Supernatent of

    unclotted blood

    Stored at -20 deg cel.

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    11/33

    SERUM

    SERUM=PLASMA

    CLOTTING

    FACTORS

    PRESERVED BY

    REFRIGERATION

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    12/33

    Blood Transfusion InVeterinary practice

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    13/33

    Introduction

    Significant increase in blood transfusionsfor over the past 20 years in small animal

    medicin

    Mostcommonly used products: whole

    blood, packed red blood cells, plasma

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    14/33

    Whole blood PLASMA

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    15/33

    Blood Types

    Canine:

    Thirteen canine blood types

    Designated by DEA (Dog Erythrocyte Antigen) & a

    number (DEA 1, DEA 2, DEA 3, etc).

    Important alleles of DEA 1: 1.1 and 1.2

    DEA 1.1 positive (most common type) => universal

    recipient DEA 1.1 and 1.2 negative => universal donor

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    16/33

    Blood Types

    Feline

    AB blood type system

    Types: A, B, AB (very rare)

    Naturally occurring alloantibodies to other blood

    groups => no universal donor in cats

    Type A cats: weak anti-B alloantibodies (weak

    reaction if transfused w/ B blood) Type B cats: high anti-A alloantibodies (severe

    reaction if transfused w/ A blood)

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    17/33

    Cross-matching Predicts a transfusion recipients response to a donors

    RBCs and plasma Majorcross-match

    detects antibodies in the recipients plasma that can cause ahemolytic reaction to donor RBCs

    Minorcross-match detects antibodies in the donors plasma that might react to

    recipients RBCs

    RBC agglutination = Incompatibility

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    18/33

    Incubation for 15min at 37C,room temperature , and

    4C

    CROSSMATCH DONOR(ml) RECIPIENT(ml)

    RED CELL SERUM RED CELL SERUM

    MAJOR 0.1 --- --- 0.1

    MINOR --- 0.1 0.1 ---

    DONOR CONTROL 0.1 0.1 --- ---

    RECIPIENT CONT. ---- --- 0.1 0.1

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    19/33

    Cross-matching - Canine

    Dogs lack naturally occurring alloantibodies =>

    a cross-match does not need to be performed

    on a patient receiving a transfusion for the

    first time

    Sensitization takes about 3 days

    No cross-match needed if transfused within the

    previous 72 hours

    Cross-match becomes necessary 72 hours after a

    dog receives a transfusion

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    20/33

    Cross-matching - Feline

    All cats should be cross-matchedif blood type is

    unknown or typing card unavailable

    D

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    21/33

    Donors

    Canine

    Good generalhealth

    Between 1-8 years ofage

    Minimum weightof 25 Kg (55 lb) - allows 450 mL ofblood to be collected

    PCVshould be 40%

    Currenton vaccinations (DALPP, Rabies)

    Yearly exam and full CBC/Chemistry / heartwormantigen test

    Infectious diseases screening:.>Donors should not have had any previoustransfusions because of risk to foreign RBC antigens

    and the development of antibodies

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    22/33

    TRANSFUSION IN LARGE ANIMALS

    OCCASIONAL

    SHOULD BE Checked for compatibility

    Done in babesiosis,anemia,blood loss etcBiological compatibility test(10 ml blood iv)

    Isttransfusionno risk

    2ndtransfusion-risk

    C i Bl d C ll ti

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    23/33

    Canine Blood Collection

    Donorin lateral recumbency

    Fur over the jugular vein is clippedand aseptically prepped

    A 16g needle is inserted into the jugular vein

    The bag is gently rocked back and forth as it fills,

    distributing the anti-coagulant(63ml CPDA)evenly; the sample is periodically weighed untilthe proper volume is achieved

    Canine units are usually450 mL or 450 grams The hemostat is clamped back

    Pressure is applied to jugular vein to preventhematoma

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    24/33

    Dosages

    ACD@15ml per 100 ml bloodCPD and CPDA-1 @14ml per 100 ml

    blood

    at 2 to 6C, ACD whole blood and CPD

    whole blood can be used within 21 days

    after collection. (70% live rbc)In CPDA-135 DAYS

    Heparin less used

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    25/33

    Administration

    Blood products should be allowed tocome to room temperature beforeadministration

    Plasma is thawed by placing theplasma in a protective plastic bag andsubmerging it in a warm water bathnot exceeding 98.6 F (37 C) - 30-60minutes is generally adequate forthawing.

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    26/33

    Administration

    Several routes may be used for administeringblood products

    Intravenous (via 22-18g IVC) is the most common

    and effective, delivering blood products directlyinto circulation

    Intraosseous is also effective when vascular

    access is difficult or unsuccessful and often usedfor neonates

    Intraperitoneal

    Plasma transfusion: for clotting factors

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    27/33

    Plasma transfusion: for clotting factors

    170-220 m in-line filter

    Smaller doses may be given via a 17um Hemo-nate

    filter Filters prevent protein debris, cellular debris, and

    blood clots from passing to the patient

    Blood products may be infused via free drip,

    syringe pump and fluid pump

    Amount of donor whole blood (ml) required:

    = 90 x BW (kg) x Desired PCV-Actual PCVDonor PCV

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    28/33

    Administration Administration rates are variable

    Patients with massive hemorrhagemayrequire a rapid transfusion

    Patients with chronic anemia need a slower infusion

    Blood components should always be infused slowly (1mL/kg) for the initial 15-30 minutes while observing fortransfusion reaction

    Subsequently, the rate may be increased to 5-10

    mL/kg/hr The blood product should be infused as quickly as the

    patient can safely tolerate, while maintaining detailedmonitoring

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    29/33

    Reactions

    Immune-mediated Hemolytic

    Acute

    Delayed Non-hemolytic

    Non-immune-mediated

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    30/33

    ReactionSIGNS

    Chills, Fever, Urticaria, Tachycardia,Dyspnea, Nausea and vomiting,Tightness in the chest, chest ,

    HHypotension, Bronchospasm,Angioneurotic edema, Anaphylaxis,Shock, Pulmonary edema, and

    Congestivefailure

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    31/33

    MANAGEMENT OF RXNS

    Treatment depends on the severityDiscontinuing thtransfusion

    +administering drugs to stop the

    hypersensitivity reaction Like CPM,

    coticosteriods,adrenaline.

    Once medications have taken effect and the patientis stabilized, the transfusion may be continued

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    32/33

    COMPLICATIONS

    Hypocalcemia

    Fluid OVERLOAD

    Disease transmission

    COAGULOPATHIES(HEPARIN)

  • 7/29/2019 BLOOD AND BLOOD COMPONENTS COLLECTION.ppt

    33/33

    THANKS

    i